Suppr超能文献

维持性血液透析患者左旋肉碱补充期间和之后血清肉碱酯的动态适应性变化。

Dynamic adaptive changes of the serum carnitine esters during and after L-carnitine supplementation in patients with maintenance haemodialysis.

机构信息

Department of Medical Genetics, University of Pécs, Clinical Center, Pécs, Hungary.

出版信息

Scand J Clin Lab Invest. 2011 Jul;71(4):280-6. doi: 10.3109/00365513.2011.560674. Epub 2011 Mar 3.

Abstract

BACKGROUND

Here we report the serum carnitine ester profile during and after 1g iv/day L-carnitine supplementation in haemodialysis patients.

MATERIALS AND METHODS

Seven patients were studied over 29 weeks. After a control day, 12 weeks of replacement therapy was introduced followed by 17 weeks of washout period. The serum acylcarnitine concentrations were determined by isotope dilution ESI MS/MS technique.

RESULTS

At baseline significantly decreased free carnitine (48%, p < 0.01) and a 1.5-16-fold elevation of 16 out of 27 acylcarnitines were detected in HD patients compared with the controls. On the last day of L-carnitine supplementation a 1.6-4.8-fold increase was observed in the acylcarnitine levels compared with day 0; the increase-profile was achieved in four different patterns. The increase rate was rapid and early saturable for C5, C5OH, C6DC, C8:1, C10DC and C18:2 esters, slower for C2, C4, C6, C18 and C18:1 esters, it was slowest and reached a late plateau for C3, C8DC, C14:2, C16 and C16:1, and finally almost gradual increase was seen for 11 acylcarnitines. Three months after the cessation of carnitine treatment marked concentration drops were found for almost all acylcarnitines (by 11-74 % of week 12, p < 0.05); the values further decreased over the five remaining weeks of the observation period.

CONCLUSION

Carnitine administration affected the levels of circulating esters in different dynamics and kinetics suggesting a regulated, non-random adaptive reallocation of nutrients. A considerable washout was achieved 3 months after discontinuation of the supplementation; however, the profile still was suggestive for presence of rest of accumulated supplement.

摘要

背景

本研究报道了血液透析患者每天静脉滴注 1g 左旋肉碱治疗期间和治疗结束后血清肉碱酯的变化。

材料与方法

7 名患者接受了 29 周的研究。在对照日后,进行了 12 周的替代治疗,随后是 17 周的洗脱期。采用同位素稀释 ESI MS/MS 技术测定血清酰基肉碱浓度。

结果

与对照组相比,基线时血液透析患者游离肉碱显著降低(48%,p<0.01),27 种酰基肉碱中有 16 种升高了 1.5-16 倍。在左旋肉碱补充的最后一天,与第 0 天相比,酰基肉碱水平升高了 1.6-4.8 倍;这种增加模式呈四种不同的形态。C5、C5OH、C6DC、C8:1、C10DC 和 C18:2 酯的增加速度快且早期达到饱和,C2、C4、C6、C18 和 C18:1 酯的增加速度较慢,C3、C8DC、C14:2、C16 和 C16:1 的增加速度最慢,达到后期平台期,最后 11 种酰基肉碱几乎呈逐渐增加。肉碱治疗停止 3 个月后,几乎所有酰基肉碱的浓度都明显下降(与第 12 周相比下降 11-74%,p<0.05);在观察期的剩余 5 周内,这些值进一步下降。

结论

肉碱的给予以不同的动力学和时间动态影响循环酯的水平,提示存在受调节的、非随机的营养物质再分配。补充停止 3 个月后,肉碱的清除量很大,但仍提示存在部分蓄积的补充剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验